A new device that slowly releases eye medication may one day be a promising option for the many glaucoma patients who struggle with administering their own daily prescription eye drops.
The new technique could lead to more precise dosing of drugs, including some potentially toxic medicines often delivered in intensive care units.
Researchers have identified a vital supply route that cancer cells use to obtain their nutrients.
The second-biggest U.S. drugmaker on Thursday nudged up its 2016 financial forecasts and its shares edged up in premarket trading.
Entresto has struggled to penetrate the chronic heart failure market, achieving dismal sales in the US since its launch in July 2015.
The formulation, indication and dosages of Trintellix remain the same as that of Brintellix.
The Food and Drug Administration issued a warning on Tuesday that reports of compulsive binge-eating, shopping, gambling, and sex have been connected to the antipsychotic Abilify.
Clinical trials by Zarate and others have shown that ketamine can lift depression in hours, or even minutes.
AstraZeneca has marketed Daliresp in the US since the acquisition of the rights from Actavis in the first quarter of 2015.
Specialty drugs and retail expansions boosted CVS Health's first-quarter revenue by 18.9 percent, helping to offset higher costs and push results above Wall Street expectations.
The drug was tested on 421 patients with a history of inadequate pain relief or intolerance to current pain killers.
Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.
Testing for health conditions usually involves needles, X-rays and other invasive or uncomfortable measures.
Synthesis of the nanogel capsules and the related measurements were conducted in Europe.
Biogen announced the company plans to spin off its hemophilia drug business as a publicly traded company, and instead concentrate on developing treatments for neurodegenerative diseases, primarily multiple sclerosis (MS). The move is surprising analysts.